These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16301758)

  • 1. Reverse epidemiology: paradoxical observations in haemodialysis patients.
    Nurmohamed SA; Nubé MJ
    Neth J Med; 2005 Nov; 63(10):376-81. PubMed ID: 16301758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.
    Kalantar-Zadeh K; Block G; Horwich T; Fonarow GC
    J Am Coll Cardiol; 2004 Apr; 43(8):1439-44. PubMed ID: 15093881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a reversal of reverse epidemiology in renal transplant recipients?
    Chavalitdhamrong D; Danovitch GM; Bunnapradist S
    Semin Dial; 2007; 20(6):544-8. PubMed ID: 17991202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis.
    Kovesdy CP; Anderson JE
    Semin Dial; 2007; 20(6):566-9. PubMed ID: 17991206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity in haemodialysis: the paradox].
    Kunz K; Hannedouche T
    Nephrol Ther; 2009 Jul; 5 Suppl 5():S339-45. PubMed ID: 19761970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease?].
    Lizicárová D; Hirnerová E; Krahulec B
    Vnitr Lek; 2010 Oct; 56(10):1088-92. PubMed ID: 21105458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
    Wan RK; Mark PB; Jardine AG
    Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and survival in hemodialysis patients.
    Lynn KL
    Semin Dial; 2004; 17(4):270-4. PubMed ID: 15250916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS.
    Horwich TB; Fonarow GC
    Semin Dial; 2007; 20(6):549-53. PubMed ID: 17991203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.